Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker’s immunology pipeline.
Related Posts
EU Confirms Tariffs on Chinese-Made EVs
The European Union confirmed plans to impose additional tariffs on electric cars made in China, dashing hopes of a solution sought by several carmakers whose […]
Masimo Taps Katie Szyman as Permanent CEO
- staff
- January 21, 2025
- 0
Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.
Zillow Promotes Operating Chief Jeremy Wacksman to Chief Executive Role
Outgoing CEO and co-founder Rich Barton will remain on Zillow’s board as co-executive chair alongside co-founder Lloyd Frink.